Redefining the stress cortisol response to surgeryBernard Khoo, Tricia Tan, Piers R. Boshier et al.|Clinical Endocrinology|2017Cited by 65
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumorsRuth Plummer, Nagy Habib, Nina Raulf et al.|Cell Reports Medicine|2025Cited by 12